Skip to main content
Erschienen in: Journal of Public Health 3/2014

01.06.2014 | Original Article

Impact of gender and age on risk factor distribution and health perception: evaluation in a prospective population with heart disease

verfasst von: Sabine Oertelt-Prigione, Friederike Kendel, Elke Lehmkuhl, Roland Hetzer, Vera Regitz-Zagrosek

Erschienen in: Journal of Public Health | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Aim

Several large surveys have highlighted the inadequate risk factor control in populations at elevated cardiovascular risk. These populations would substantially benefit from risk reduction and could demonstrate increased awareness for risk factor control. Risk factor segregation by gender has been previously described, yet its analysis in the medical field frequently omits sociodemographic variables, which could act as potential confounders.

Subject and methods

We analyzed risk factor prevalence in a population of 1,559 patients with severe coronary heart disease prior to a coronary bypass graft (CABG) surgery. Univariate correlations between risk factor type and frequency and gender were explored. Following, multivariable models were fitted to account for sociodemographic aspects associated with gender. Interaction terms were incorporated as fit. Lastly, the correlation between gender-specific risk factor profiles and their association with self-perceived health status was assessed.

Results

Our study identified gender as the main segregating variable for risk factors after multiple adjustments and inclusion of interaction terms. Obesity and hypertension displayed a significant association with the female population (OR = 1.598, p = 0.047 and OR = 3.737, p = 0.006, respectively), while smoking and elevated alcohol consumption prevailed in males (OR = 1.77, p = 0.038 and OR = 2.768, p = 0.013, respectively). Additionally, gender-specific analysis of health perception according to risk factor loads revealed that male patients rate their health in overall better terms regardless of their risk profile.

Conclusions

Our study confirmed the role of gender as the primary risk profile segregator after multiple adjustments for potential sociodemographic confounders, even in a population at elevated cardiovascular risk. Subjective health perception, which displayed marked gender differences, should be further investigated as a potential adherence and outcome modulator.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Bellg AJ (2003) Maintenance of health behavior change in preventive cardiology: internalization and self-regulation of new behaviors. Behav Modif 27(1):103–131PubMedCrossRef Bellg AJ (2003) Maintenance of health behavior change in preventive cardiology: internalization and self-regulation of new behaviors. Behav Modif 27(1):103–131PubMedCrossRef
Zurück zum Zitat Bird CE, Rieker PP (1999) Gender matters: an integrated model for understanding men’s and women’s health. Soc Sci Med 48(6):745–755PubMedCrossRef Bird CE, Rieker PP (1999) Gender matters: an integrated model for understanding men’s and women’s health. Soc Sci Med 48(6):745–755PubMedCrossRef
Zurück zum Zitat Bloss G (2005) Measuring the health consequences of alcohol consumption: current needs and methodological challenges. Dig Dis 23(3-4):162–169PubMedCrossRef Bloss G (2005) Measuring the health consequences of alcohol consumption: current needs and methodological challenges. Dig Dis 23(3-4):162–169PubMedCrossRef
Zurück zum Zitat Byrnes JP, Miller DC, Schafer WD (1999) Gender differences in risk taking: a meta-analysis. Psychol Bull 125(3):367–383CrossRef Byrnes JP, Miller DC, Schafer WD (1999) Gender differences in risk taking: a meta-analysis. Psychol Bull 125(3):367–383CrossRef
Zurück zum Zitat Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, Kiefe CI, Frederick PD, Sopko G, Zheng ZJ (2012) Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 307(8):813–822PubMedCrossRef Canto JG, Rogers WJ, Goldberg RJ, Peterson ED, Wenger NK, Vaccarino V, Kiefe CI, Frederick PD, Sopko G, Zheng ZJ (2012) Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 307(8):813–822PubMedCrossRef
Zurück zum Zitat Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D (2011) ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 217(1):3–46PubMedCrossRef Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D (2011) ESC/EAS guidelines for the management of dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 217(1):3–46PubMedCrossRef
Zurück zum Zitat Driscoll A, Beauchamp A, Lyubomirsky G, Demos L, McNeil J, Tonkin A (2011) Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women. Intern Med J 41(10):730–736PubMedCrossRef Driscoll A, Beauchamp A, Lyubomirsky G, Demos L, McNeil J, Tonkin A (2011) Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women. Intern Med J 41(10):730–736PubMedCrossRef
Zurück zum Zitat EUROASPIRE II Euro Study Group (2001) Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22 (7):554–572 EUROASPIRE II Euro Study Group (2001) Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries: principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22 (7):554–572
Zurück zum Zitat Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, Pyorala K (2004) Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47(7):1245–1256PubMed Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens EJ, Pyorala K (2004) Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies. Diabetologia 47(7):1245–1256PubMed
Zurück zum Zitat Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378(9799):1297–1305PubMedCrossRef Huxley RR, Woodward M (2011) Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 378(9799):1297–1305PubMedCrossRef
Zurück zum Zitat Kappert K, Bohm M, Schmieder R, Schumacher H, Teo K, Yusuf S, Sleight P, Unger T (2012) Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects with Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial (ONTARGET). Circulation 126(8):934–941PubMedCrossRef Kappert K, Bohm M, Schmieder R, Schumacher H, Teo K, Yusuf S, Sleight P, Unger T (2012) Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects with Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination with Ramipril Global End point Trial (ONTARGET). Circulation 126(8):934–941PubMedCrossRef
Zurück zum Zitat Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290(7):898–904PubMedCrossRef Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290(7):898–904PubMedCrossRef
Zurück zum Zitat Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U (2009) EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16(2):121–137PubMedCrossRef Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U (2009) EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 16(2):121–137PubMedCrossRef
Zurück zum Zitat Lange C, Ziese T (2011) Daten und Fakten: Ergebnisse der Studie “Gesundheit in Deutschland aktuell 2009“. Robert Koch Institut, Berlin Lange C, Ziese T (2011) Daten und Fakten: Ergebnisse der Studie “Gesundheit in Deutschland aktuell 2009“. Robert Koch Institut, Berlin
Zurück zum Zitat Lombardi M, Mercuro G, Fini M, Rosano GM (2010) Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention. Fund Clin Pharmacol 24(6):699–705CrossRef Lombardi M, Mercuro G, Fini M, Rosano GM (2010) Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention. Fund Clin Pharmacol 24(6):699–705CrossRef
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A (2007) 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 25(9):1751–1762PubMedCrossRef Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A (2007) 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 25(9):1751–1762PubMedCrossRef
Zurück zum Zitat Oertelt-Prigione S, Parol R, Krohn S, Preissner R, Regitz-Zagrosek V (2010) Analysis of sex and gender-specific research reveals a common increase in publications and marked differences between disciplines. BMC Med 8:70PubMedCentralPubMedCrossRef Oertelt-Prigione S, Parol R, Krohn S, Preissner R, Regitz-Zagrosek V (2010) Analysis of sex and gender-specific research reveals a common increase in publications and marked differences between disciplines. BMC Med 8:70PubMedCentralPubMedCrossRef
Zurück zum Zitat Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88–136PubMed Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88–136PubMed
Zurück zum Zitat Towfighi A, Zheng L, Ovbiagele B (2009) Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 169(19):1762–1766PubMedCrossRef Towfighi A, Zheng L, Ovbiagele B (2009) Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 169(19):1762–1766PubMedCrossRef
Zurück zum Zitat Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R (2011) Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology. Cardiovasc Res 90(1):9–17PubMedCentralPubMedCrossRef Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R (2011) Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology. Cardiovasc Res 90(1):9–17PubMedCentralPubMedCrossRef
Zurück zum Zitat Vitale C, Mendelsohn ME, Rosano GM (2009) Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 6(8):532–542PubMedCrossRef Vitale C, Mendelsohn ME, Rosano GM (2009) Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 6(8):532–542PubMedCrossRef
Zurück zum Zitat Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 273(1):59–65PubMedCrossRef Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 273(1):59–65PubMedCrossRef
Zurück zum Zitat Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O (2008) Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371(9629):1999–2012PubMedCrossRef Wood DA, Kotseva K, Connolly S, Jennings C, Mead A, Jones J, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O (2008) Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371(9629):1999–2012PubMedCrossRef
Zurück zum Zitat Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952PubMedCrossRef Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952PubMedCrossRef
Metadaten
Titel
Impact of gender and age on risk factor distribution and health perception: evaluation in a prospective population with heart disease
verfasst von
Sabine Oertelt-Prigione
Friederike Kendel
Elke Lehmkuhl
Roland Hetzer
Vera Regitz-Zagrosek
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Public Health / Ausgabe 3/2014
Print ISSN: 2198-1833
Elektronische ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-013-0609-0

Weitere Artikel der Ausgabe 3/2014

Journal of Public Health 3/2014 Zur Ausgabe